Macrogen has pioneered genome sequencing and testing in Korea, becoming a reference company and supporting the development of technology in the country. However, it would be wrong to limit Macrogen's ...
Bernstein analyst Eve Burstein lowered the firm’s price target on Illumina (ILMN) to $140 from $145 and keeps a Market Perform rating on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback